Jiangsu Bioperfectus Technologies Co

Jiangsu Bioperfectus Technologies Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Jiangsu Bioperfectus Technologies Co (688399.SS) as of Oct 15, 2026 is 85.90 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -4,149.69 % — a change of -102.07% (higher).

FCF Conversion

85.90 %

YoY

-102.07%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Jiangsu Bioperfectus Technologies Co is 2025 85.90 % . FCF Conversion Rate (FCF/EBITDA) of Jiangsu Bioperfectus Technologies Co was 2024 -4,149.69 % . It decreases by -102.07% higher compared to the previous year.

The Jiangsu Bioperfectus Technologies Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-20.24 CNY
Jan 1, 2019
1.13 CNY
Jan 1, 2020
97.77 CNY
Jan 1, 2021
57.15 CNY
Jan 1, 2022
88.31 CNY
Jan 1, 2023
60.05 CNY
Jan 1, 2024
-4,149.69 CNY
Jan 1, 2025
85.90 CNY
The Jiangsu Bioperfectus Technologies Co FCF Conversion history
YEARFCF ConversionYoY
85.90 %-102.07%
-4,149.69 %-7,010.07%
60.05 %-31.99%
88.31 %+54.52%
57.15 %-41.55%
97.77 %+8,572.49%
1.13 %-105.57%
-20.24 %-126.75%
75.67 %-2,365.23%
-3.34 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Jiangsu Bioperfectus Technologies Co Stock analysis

What does Jiangsu Bioperfectus Technologies Co do? Jiangsu Bioperfectus Technologies Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jiangsu Bioperfectus Technologies Co stock

FCF Conversion Rate (FCF/EBITDA) of Jiangsu Bioperfectus Technologies Co is 85.90 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Jiangsu Bioperfectus Technologies Co changed from -4,149.69 % to 85.90 %, representing a -102.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Jiangsu Bioperfectus Technologies Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Jiangsu Bioperfectus Technologies Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Jiangsu Bioperfectus Technologies Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Jiangsu Bioperfectus Technologies Co